Virtual school on rare lung diseases in collaboration with ERN-LUNG

This European Respiratory Society (ERS) / European Reference Network (ERN-LUNG) collaborative course will present the latest understanding and advice on the management of rare lung diseases. Due to the small number of people affected with rare lung diseases, diagnosis can be difficult and treatment options are limited.

This online course will provide an overview on how to diagnose and treat rare lung diseases, including interstitial lung diseases, pulmonary hypertension, cystic fibrosis, primary ciliary dyskinesia, non-cystic fibrosis bronchiectasis, rare obstructive lung diseases and rare thoracic cancers.

Participants will benefit from round table discussions, case-based sessions, and the opportunity to present their pre-recorded cases and discuss them with leading experts.

An application will be submitted to EBAP (European Board for Accreditation in Pneumology) for CME accreditation of this event. The number of credits that you will receive will correspond to the time you spend viewing the sessions live. Please note that you will not accrue credits for watching video recordings made available after the course has taken place.

Course format

• Lectures
• Case presentations, with interactive discussions
• Round table discussions
• Case based sessions, with cases submitted by participants

Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants after the event.

Topics

• Interstitial lung diseases
• Pulmonary hypertension
• Cystic fibrosis
• Primary ciliary dyskinesia
• Non-cystic fibrosis bronchiectasis
• Rare obstructive lung diseases
• Rare thoracic malignancies

Learning outcomes

Following this course, participants will be able to:

• Have greater insights into the diagnosis of rare lung diseases
• Have an understanding on newest treatment approaches of rare lung diseases
• Adapt multidisciplinary approaches to rare lung diseases in their daily practice

Target audience

• Adult Pulmonologists
• Paediatric pulmonologists
• Respiratory clinicians
• Pulmonologists in training
• Paediatricians
• Allied healthcare professionals
• Patients